Glycine Transporter-1 Inhibitors as Novel Therapeutic Drugs for Schizophrenia

E-ISSN： 1875-6166|7|3|177-182

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.7, Iss.3, 2007-09, pp. : 177-182

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glycine Site Modulators and Glycine Transporter-1 Inhibitors as Novel Therapeutic Targets for the Treatment of Schizophrenia

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 35-43

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of glycine transporter-1 inhibitors

By Sur Cyrille Kinney Gene G

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 515-521

Informa Healthcare

Access to resources Recommend Favorite

PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia

Current Pharmaceutical Design, Vol. 17, Iss. 2, 2011-01 ,pp. : 112-120

Bentham Science Publishers

Access to resources Recommend Favorite

Glycine Reuptake Inhibition as a New Therapeutic Approach in Schizophrenia: Focus on the Glycine Transporter 1 (GlyT1)

Current Pharmaceutical Design, Vol. 19, Iss. 7, 2013-02 ,pp. : 1311-1320

Bentham Science Publishers

Access to resources Recommend Favorite